marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
Harvard Bioscience Balance Sheet 2011-2024 | HBIO
Annual Balance Sheet Harvard Bioscience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
27.8 M | 40.6 M | 39.4 M | 39.7 M | 45.5 M | 52.6 M | 6.02 M | 8.15 M | 12.2 M | 7.32 M | -1.02 M | -7.73 M | -1.62 M |
Long Term Debt |
30.7 M | 43 M | 45.1 M | 46.3 M | 46.9 M | 58.8 M | 8.98 M | 11.4 M | 16.4 M | 16.4 M | 19.8 M | 13 M | 16.3 M |
Long Term Debt Current |
1.42 M | 2.14 M | 2.14 M | 2.11 M | 2.42 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 58.5 M | 57.9 M | 64.4 M | 14.4 M | 21 M | 23.2 M | 22.3 M | 24.9 M | 19.4 M | 21.6 M |
Total Current Liabilities |
26.5 M | 23.2 M | 25.3 M | 21.1 M | 25.3 M | 21.5 M | 14 M | 14.6 M | 19.4 M | 18.1 M | 16.1 M | 9.9 M | 9.56 M |
Total Liabilities |
64.3 M | 73.1 M | 78.9 M | 79.6 M | 83.2 M | 85.9 M | 28.5 M | 35.6 M | 42.6 M | 40.4 M | 41 M | 29.3 M | 31.1 M |
Deferred Revenue |
4.51 M | 3.37 M | 4.27 M | 3.77 M | 3.95 M | 4.19 M | 633 K | 500 K | 752 K | 655 K | 640 K | 482 K | 483 K |
Retained Earnings |
-146 M | -142 M | -133 M | -132 M | -125 M | -120 M | -117 M | -116 M | -112 M | -92.7 M | -95 M | -77.3 M | -79.6 M |
Total Assets |
137 M | 145 M | 162 M | 156 M | 165 M | 169 M | 109 M | 108 M | 120 M | 136 M | 135 M | 133 M | 127 M |
Cash and Cash Equivalents |
4.28 M | 4.51 M | 7.82 M | 8.32 M | 8.34 M | 8.17 M | 5.19 M | 5.6 M | 6.74 M | 14.1 M | 25.8 M | 20.7 M | 17.9 M |
Book Value |
73.1 M | 72.2 M | 83.4 M | 76.7 M | 81.7 M | 82.7 M | 80.9 M | 72.2 M | 77.6 M | 95.5 M | 94.5 M | 104 M | 95.5 M |
Total Shareholders Equity |
73.1 M | 72.2 M | 83.4 M | 76.7 M | 81.7 M | 82.7 M | 80.9 M | 72.2 M | 77.6 M | 95.5 M | 94.5 M | 104 M | 95.5 M |
All numbers in USD currency
Quarterly Balance Sheet Harvard Bioscience
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
34.3 M | 32 M | 31.9 M | 30.7 M | 35.3 M | 38.2 M | 41.1 M | 43 M | - | - | 46.2 M | 45.1 M | 42.7 M | 40.9 M | 41.6 M | 46.3 M | 46.3 M | 46.3 M | 46.3 M | 46.9 M | 46.9 M | 46.9 M | 46.9 M | 54.8 M | 54.8 M | 54.8 M | 54.8 M | 8.98 M | 8.98 M | 8.98 M | 8.98 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 19.8 M | 19.8 M | 21.2 M | 19.8 M | 13 M | 13 M | 13 M | 13 M | 16.3 M | 16.3 M | 16.3 M | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
65.9 M | 61.7 M | 64.3 M | 64.3 M | 65.4 M | 67.5 M | 71.2 M | 73.1 M | - | - | 81.7 M | 78.9 M | 77 M | 75.3 M | 74.1 M | 79.6 M | 79.6 M | 79.6 M | 79.6 M | 83.2 M | 83.2 M | 83.2 M | 83.2 M | 85.9 M | 85.9 M | 85.9 M | 85.9 M | 28.5 M | 28.5 M | 28.5 M | 28.5 M | 35.6 M | 35.6 M | 35.6 M | 35.6 M | 42.5 M | 42.5 M | 42.5 M | 42.5 M | 40.4 M | 40.4 M | 40.4 M | 40.4 M | 41 M | 41 M | 40.7 M | 41 M | 29.3 M | 29.3 M | 29.3 M | 29.3 M | 31.1 M | 31.1 M | 31.1 M | - |
Deferred Revenue |
3.69 M | 4.01 M | 4.39 M | 4.51 M | 4 M | 3.84 M | 4.12 M | 3.37 M | - | - | 3.96 M | 4.27 M | 3.62 M | 3.68 M | 3.64 M | 3.77 M | 3.77 M | 3.77 M | 3.77 M | 3.95 M | 3.55 M | 3.53 M | 3.72 M | 3.82 M | 3.27 M | 3.82 M | 3.82 M | 505 K | 505 K | 505 K | 505 K | 500 K | 500 K | 500 K | 500 K | 752 K | 752 K | 752 K | 752 K | 655 K | 655 K | 655 K | 655 K | 640 K | 640 K | 740 K | 640 K | 482 K | 482 K | 482 K | 482 K | 483 K | 483 K | 483 K | - |
Retained Earnings |
-158 M | -153 M | -150 M | -146 M | -144 M | -143 M | -142 M | -142 M | - | - | -140 M | -133 M | -134 M | -133 M | -133 M | -132 M | -132 M | -132 M | -132 M | -125 M | -125 M | -125 M | -125 M | -120 M | -120 M | -120 M | -120 M | -117 M | -117 M | -117 M | -117 M | -116 M | -116 M | -116 M | -116 M | -112 M | -112 M | -112 M | -112 M | -92.7 M | -92.7 M | -92.7 M | -92.7 M | -95 M | -95 M | -77.4 M | -95 M | -77.3 M | -77.3 M | -77.3 M | -77.3 M | -79.6 M | -79.6 M | -79.6 M | - |
Total Assets |
131 M | 129 M | 133 M | 137 M | 140 M | 143 M | 146 M | 145 M | - | - | 158 M | 162 M | 154 M | 154 M | 151 M | 156 M | 156 M | 156 M | 156 M | 165 M | 165 M | 165 M | 165 M | 169 M | 169 M | 169 M | 169 M | 109 M | 109 M | 109 M | 109 M | 108 M | 108 M | 108 M | 108 M | 120 M | 120 M | 120 M | 120 M | 136 M | 136 M | 136 M | 136 M | 135 M | 135 M | 146 M | 135 M | 133 M | 133 M | 133 M | 133 M | 127 M | 127 M | 127 M | - |
Cash and Cash Equivalents |
4.57 M | 4.05 M | 4.26 M | 4.28 M | 5.34 M | 4.32 M | 3.79 M | 4.51 M | - | - | 5.43 M | 7.82 M | 5.55 M | 6.24 M | 5.82 M | 8.32 M | 8.32 M | 8.32 M | 8.32 M | 8.34 M | 8.34 M | 8.34 M | 8.34 M | 8.17 M | 8.17 M | 8.17 M | 8.17 M | 5.73 M | 5.19 M | 5.19 M | 5.19 M | 5.6 M | 5.6 M | 5.6 M | 5.6 M | 6.74 M | 6.74 M | 6.74 M | 6.74 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 25.8 M | 25.8 M | 36.9 M | 25.8 M | 20.7 M | 20.7 M | 20.7 M | 20.7 M | 17.9 M | 17.9 M | 17.9 M | 20.1 M |
Book Value |
65.3 M | 67.2 M | 68.8 M | 73.1 M | 74.3 M | 75.4 M | 74.3 M | 72.2 M | - | - | 76.4 M | 83.4 M | 76.9 M | 78.7 M | 77.1 M | 76.7 M | 76.7 M | 76.7 M | 76.7 M | 81.7 M | 81.7 M | 81.7 M | 81.7 M | 82.7 M | 82.7 M | 82.7 M | 82.7 M | 80.9 M | 80.9 M | 80.9 M | 80.9 M | 72.2 M | 72.2 M | 72.2 M | 72.2 M | 77.6 M | 77.6 M | 77.6 M | 77.6 M | 95.5 M | 95.5 M | 95.5 M | 95.5 M | 94.5 M | 94.5 M | 105 M | 94.5 M | 104 M | 104 M | 104 M | 104 M | 95.5 M | 95.5 M | 95.5 M | - |
Total Shareholders Equity |
65.3 M | 67.2 M | 68.8 M | 73.1 M | 74.3 M | 75.4 M | 74.3 M | 72.2 M | 72 M | 77.5 M | 76.4 M | 83.4 M | 76.9 M | 78.7 M | 77.1 M | 76.7 M | 76.7 M | 76.7 M | 76.7 M | 81.7 M | 81.7 M | 81.7 M | 81.7 M | 82.7 M | 82.7 M | 82.7 M | 82.7 M | 80.9 M | 80.9 M | 80.9 M | 80.9 M | 72.2 M | 72.2 M | 72.2 M | 72.2 M | 77.6 M | 77.6 M | 77.6 M | 77.6 M | 95.5 M | 95.5 M | 95.5 M | 95.5 M | 94.5 M | 94.5 M | 105 M | 94.5 M | 104 M | 104 M | 104 M | 104 M | 95.5 M | 95.5 M | 95.5 M | - |
All numbers in USD currency